Santero Therapeutics
PrivateLast Round
Series A
Jun 7, 2023
Total Funding Raised
$8.67M
Company Overview
Santero Therapeutics operates in Healthcare & Life Sciences and is based in Mont-Saint-Guibert. Its latest recorded funding round was a Series A round in June 2023.
Santero Therapeutics is a biotechnology company that develops first-in-class small molecule antibiotics to combat multidrug-resistant pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Santero Therapeutics Comparables
Compare Santero Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| smartbax GmbH | 83% | |
| ArrePath | 79% | |
| Telum Therapeutics | 79% |
For institutional investors. Book with your work email.
Santero Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Santero Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A |
| Newton Biocapital | Series A |
| Wallonie Entreprendre | Series A |
| Sambrinvest | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Cuong Vuong appointed as new Chief Scientific Officer.
- Feb 25, 2025
Will speak at the AMR Conference in Basel on Feb 25-26, 2025.
For institutional investors. Book with your work email.
Santero Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Santero Therapeutics's valuation, stock price, and market status.
Is Santero Therapeutics a public or private company?
Santero Therapeutics is a private company.
What is the current stock price of Santero Therapeutics?
Santero Therapeutics is a private company, so its shares have no public market price. Caplight tracks Santero Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Santero Therapeutics worth (valuation)?
Valuation information for Santero Therapeutics is not publicly available.
Can I buy Santero Therapeutics stock?
Santero Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Santero Therapeutics's last funding round?
Santero Therapeutics's most recent funding round was Series A on June 7, 2023.
Who are the main investors in Santero Therapeutics?
Key investors in Santero Therapeutics include Newton Biocapital.
Will Santero Therapeutics IPO soon?
No public IPO plans have been announced for Santero Therapeutics.
How can I track Santero Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Santero Therapeutics's shares on secondary markets.